NMPA Approval

Upadacitinib Sustained - release Tablets

Approval Number

国药准字HJ20233125

Registration Date

February 14, 2023

Drug Information

Generic Name

乌帕替尼缓释片

Trade Name

瑞福

Dosage Form

片剂

Strength

45mg（按C₁₇H₁₉F₃N₆O计）

Drug Type

化学药品

Registration Date

February 14, 2023

Expiry Date

February 13, 2028

Company Address

Knollstrasse, 67061 Ludwigshafen, Germany.

Company Address

Manorhamilton Road, Sligo, Ireland.

Empowering clinical research with data-driven insights and AI-powered tools.

乌帕替尼缓释片 - NMPA 批准文号 | MedPath